BIB_133
De Giorgi V et al. Propranolol for Off-label Treatment of Patients With Melanoma: Cohort Study. JAMA Oncology 2018. PMID 28973254. n = 53 PROP + 79 No-PROP, stage IB-IIIA cutaneous melanoma, propranolol 80 mg daily; PFS benefit signal. [Tasks: 12] Tier: 3 Grade: B Retrieved: 2026-05-07
- Evidence grade
- B
- Tier
- 3
- Cited by tasks
- 12
- Identifiers
- PMID:28973254
↗ Follow the original source for full context
Full extracted findings & patient-implication analysis: bibliography/BIB_133/findings.md (research corpus). This page is a short context summary — not individualised medical advice.